Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 INDOCO REMEDIES   ADCOCK INGRAM
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-23
ADCOCK INGRAM
Jun-14
INDOCO REMEDIES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs423320-   
Low Rs308231-   
Sales per share (Unadj.) Rs181.195.3-  
Earnings per share (Unadj.) Rs15.4-24.0-  
Cash flow per share (Unadj.) Rs23.1-19.9-  
Dividends per share (Unadj.) Rs2.250-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs111.574.8-  
Shares outstanding (eoy) m92.15168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.02.9 69.8%   
Avg P/E ratio x23.7-11.5 -206.2%  
P/CF ratio (eoy) x15.8-13.9 -114.2%  
Price / Book Value ratio x3.33.7 88.9%  
Dividend payout %14.60-   
Avg Mkt Cap Rs m33,68346,551 72.4%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m3,2262,922 110.4%   
Avg. sales/employee Rs Th03,747.7-  
Avg. wages/employee Rs Th0680.6-  
Avg. net profit/employee Rs Th0-944.3-  
INCOME DATA
Net Sales Rs m16,68616,089 103.7%  
Other income Rs m24113 21.2%   
Total revenues Rs m16,71016,201 103.1%   
Gross profit Rs m2,860-2,788 -102.6%  
Depreciation Rs m706694 101.7%   
Interest Rs m250436 57.4%   
Profit before tax Rs m1,928-3,806 -50.7%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m505238 212.5%   
Profit after tax Rs m1,423-4,054 -35.1%  
Gross profit margin %17.1-17.3 -98.9%  
Effective tax rate %26.2-6.2 -419.5%   
Net profit margin %8.5-25.2 -33.8%  
BALANCE SHEET DATA
Current assets Rs m8,08211,784 68.6%   
Current liabilities Rs m4,2456,630 64.0%   
Net working cap to sales %23.032.0 71.8%  
Current ratio x1.91.8 107.1%  
Inventory Days Days25111 22.6%  
Debtors Days Days768124 619.4%  
Net fixed assets Rs m9,0556,869 131.8%   
Share capital Rs m18475 246.7%   
"Free" reserves Rs m10,0920-   
Net worth Rs m10,27612,628 81.4%   
Long term debt Rs m1,4354,438 32.3%   
Total assets Rs m17,13723,855 71.8%  
Interest coverage x8.7-7.7 -112.6%   
Debt to equity ratio x0.10.4 39.7%  
Sales to assets ratio x1.00.7 144.4%   
Return on assets %9.8-15.2 -64.4%  
Return on equity %13.8-32.1 -43.1%  
Return on capital %18.6-19.8 -93.9%  
Exports to sales %47.50-   
Imports to sales %11.50-   
Net fx Rs m6,0020-   
CASH FLOW
From Operations Rs m1,7881,373 130.2%  
From Investments Rs m-2,082-422 493.7%  
From Financial Activity Rs m2284,028 5.7%  
Net Cashflow Rs m-654,979 -1.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.42 Rs / ZAR

Compare INDOCO REMEDIES With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare INDOCO REMEDIES With: UNICK FIX-A-FORM AND PRINTERS  ROOPA INDUSTRIES  MANGALAM DRUGS  SOLARA ACTIVE PHARMA SCIENCES  ADESHWAR MEDITEX  



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.